National scale-up of tuberculosis–human immunodeficiency virus collaborative activities in Myanmar from 2005 to 2016

TB treatment outcomes for patients with human immunodeficiency virus-positive TB in the Mandalay Region in 2015

Abstract

HIV-associated TB is a serious public health problem in Myanmar. Study objectives were to describe national scale-up of collaborative activities to reduce the double burden of TB and HIV from 2005 to 2016 and to describe TB treatment outcomes of individuals registered with HIV-associated TB in 2015 in the Mandalay Region. Methods: Secondary analysis of national aggregate data and, for treatment outcomes, a cohort study of patients with HIV-associated TB in the Mandalay Region.

This research was supported by the UK Department for International Development’s Operational Research Capacity Building Programme led by the International Union Against TB and Lung Disease (The Union)

Citation

Theingi P, Harries AD, Wai KT, Shewade HD, Saw S, Win T, Thein S, Kyi MS, Nyunt Oo H, Aung ST. National scale-up of tuberculosis–human immunodeficiency virus collaborative activities in Myanmar from 2005 to 2016 and tuberculosis treatment outcomes for patients with human immunodeficiency virus-positive tuberculosis in the Mandalay Region in 2015. Transactions of the Royal Society of Tropical Medicine & Hygiene. 2018;111(9):402–9.

National scale-up of tuberculosis–human immunodeficiency virus collaborative activities in Myanmar from 2005 to 2016 and tuberculosis treatment outcomes for patients with human immunodeficiency virus-positive tuberculosis in the Mandalay Region in 2015

Updates to this page

Published 19 January 2018